Fresh analysis indicates that people who come off blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who halt traditional lifestyle regimens.
Published data in a major health publication demonstrates that while overweight individuals often shed about a fifth of their body weight while using the jabs, the weight comes back at an average rate of nearly a kilo each month after stopping.
"Individuals purchasing such treatments need to be cognizant of the risk of fast rebound weight gain when the therapy is stopped," cautioned lead investigator Dr. Susan Jebb.
Such speed of regain implies a return to pre-treatment mass in about a year and a half.
Comparing Approaches
The research, which reviewed 37 of studies involving thousands of patients, contrasted the outcomes of these new drugs with older methods.
Scientists note that individuals who shed pounds through diet and exercise typically experience a less rapid creep back—around 0.1 kg a month—once they finish.
Explaining the Quick Regain
Nutrition scientists believe the mechanism of the drugs accounts for the heightened regain.
The injections imitate a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production may cause the system to produce less of its own natural GLP-1, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this medication means appetite is unsuppressed, making overeating far more likely."
A Chronic Disease?
Medical guidelines suggest the jabs for people with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians say that, due to the high risk of weight regain, the treatment is often long-term.
This perspective is reinforced by drug manufacturers, who note that the results "highlight the long-term character of obesity," similar to managing diseases like diabetes.
Patient Accounts
People who have discontinued the medication explain a intense return of hunger.
"I experienced a switch that goes on and you're instantly extremely hungry," said one woman.
This difficulty is worsened if individuals have not established lasting dietary or behavioural changes during therapy.
Significant Adoption
Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the past year, with desire continuing to grow.
- Adoption is higher among females compared to men.
- The 40s and 50s age group shows the highest usage rates.
- Many access the drugs through private prescriptions rather than the NHS.
Finally, experts stress that while these medications are potent tools for weight loss, they are not a permanent solution and maintained weight loss relies on combined behavioural management.